The microglia, in turn, seem to benefit, revving up metabolism and phagocytosis. The liver protein ApoA-I was particularly good at bolstering the latter. Overall, the findings suggest that the brain’s ...

Researchers have developed an innovative CAR T-cell therapy to combat glioblastoma, the most common malignant brain tumor in ...

Researchers from the University of Bonn are using an innovative method to watch immune receptors go about their business. ...

The alarm that they trigger starts a series of reactions inside the cells. When scavenger cells “sniff out” a bacterium, for ...

Immune cells are capable of detecting infections just like a sniffer dog, using special sensors known as Toll-like receptors, ...

Inefficient removal of dying cells results in human autoimmune and inflammatory diseases. On the other hand, targeted phagocytosis of cancer cells has recently been developed as a cancer treatment ...

Acute-on-chronic liver failure (ACLF) is a life-threatening condition characterized by acute deterioration of liver function ...

Researchers have developed a promising nasal spray therapy targeting neuroinflammation in Alzheimer’s disease, potentially ...

REVB READ THE FULL REVB RESEARCH REPORT Revelation Biosciences (NASDAQ:REVB) announced its 3Q2024 financial results which ...

Preclinical data have shown the ability of AT-02 to bind to multiple amyloid types in major organs and induce macrophage mediated amyloid phagocytosis and amyloid removal. AT-02 is currently being ...